Literature DB >> 819962

Postoperative radiotherapy in carcinomas of the rectum and distal sigmoid colon.

O A Mendiondo, C C Wang, J P Welch, G A Donaldson.   

Abstract

Twenty-seven patients with Stage B and C carcinomas of the rectum and lower sigmoid received radiotherapy following radical surgery. Local control ratios for Stages B2, B3, and C (modified Duke's) were 7/9, 2/6, and 4/12, respectively. Nine of these 13 patients are alive with no evidence of disease 4-54 mo. after treatment; the other 4 died of unrelated causes. One died of complications attributable to irradiation 6 mo. after treatment; no tumor was found at autopsy. These results suggest that postoperative irradiation plays a significant role in Stage B lesions, but prognosis for Stage C disease does not appear to be altered.

Entities:  

Mesh:

Year:  1976        PMID: 819962     DOI: 10.1148/119.3.673

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG).

Authors:  E Robinson; A Bartal; Y Cohen; N Haim; J Mohilever; T Mekori
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Adjuvant postoperative radiation therapy for Dukes C adenocarcinoma of the rectum.

Authors:  S A Localio; W Nealon; J Newall; Q Valensi
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

3.  Carcinoma of the rectum and rectosigmoid colon: role of radiation therapy.

Authors:  E K Reddy; C M Mansfield; G V Hartman
Journal:  J Natl Med Assoc       Date:  1978-11       Impact factor: 1.798

Review 4.  Adjuvant treatment of colorectal cancer. Current status and concepts.

Authors:  U F Metzger; B C Ghosh; D L Kisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre study.

Authors:  I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Sørensen; J Bone; N O Jacobsen; J Overgaard; A Sell; K Bertelsen; E Hage; L Hansen; O Kronborg; H Høstrup; B Nørgaard-Pedersen
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.